Skip to main content
PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · IEX Real-Time Price · USD
68.10
-0.04 (-0.06%)
At close: May 17, 2024, 4:00 PM
67.49
-0.61 (-0.90%)
After-hours: May 17, 2024, 6:49 PM EDT

PROCEPT BioRobotics Revenue

PROCEPT BioRobotics had revenue of $156.33M in the twelve months ending March 31, 2024, with 83.44% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $44.54M with 82.51% year-over-year growth. In the year 2023, PROCEPT BioRobotics had annual revenue of $136.19M with 81.55% growth.

Revenue (ttm)
$156.33M
Revenue Growth
+83.44%
P/S Ratio
22.41
Revenue / Employee
$249,722
Employees
626
Market Cap
3.50B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023136.19M61.18M81.55%
Dec 31, 202275.01M40.54M117.60%
Dec 31, 202134.47M26.76M346.72%
Dec 31, 20207.72M1.55M25.09%
Dec 31, 20196.17M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Surgery Partners 2.79B
LivaNova 1.19B
HUTCHMED (China) 838.00M
Ultragenyx Pharmaceutical 442.59M
Axonics 387.14M
Insmed 315.49M
Axsome Therapeutics 251.02M
Alvotech 93.38M
Revenue Rankings

PRCT News

More News